Craneware (LON:CRW) Receives “Buy” Rating from Peel Hunt

Peel Hunt reiterated their buy rating on shares of Craneware (LON:CRWFree Report) in a report issued on Monday, Marketbeat reports. Peel Hunt currently has a GBX 2,871 price target on the stock.

CRW has been the topic of a number of other reports. Berenberg Bank raised their price target on Craneware from GBX 2,800 to GBX 2,900 and gave the company a “buy” rating in a research note on Monday. Shore Capital restated a “buy” rating and issued a GBX 2,650 price target on shares of Craneware in a research note on Wednesday, July 16th. Three equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat, the stock has a consensus rating of “Buy” and an average target price of GBX 2,807.

View Our Latest Report on Craneware

Craneware Stock Up 2.6%

Craneware stock opened at GBX 2,330 on Monday. Craneware has a 1-year low of GBX 1,330 and a 1-year high of GBX 2,580. The company has a debt-to-equity ratio of 12.22, a current ratio of 0.63 and a quick ratio of 1.00. The stock has a market cap of £825.05 million, a PE ratio of 5,482.35 and a beta of 0.28. The stock’s fifty day moving average is GBX 2,277.29 and its two-hundred day moving average is GBX 2,021.57.

Craneware Company Profile

(Get Free Report)

The Craneware Group, the market leader in automated value cycle solutions, including 340B management, collaborates with U.S. healthcare providers to plan, execute, and monitor operational and financial performance so they can continue to deliver quality care to their communities. Customers choose The Craneware Group’s Trisus data and applications platform as their key to navigating the journey to financially sustainable value-based care.

See Also

Receive News & Ratings for Craneware Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Craneware and related companies with MarketBeat.com's FREE daily email newsletter.